Skip to content

Mindfulness-Based Stress Reduction 'MBSR' impact on PolyCystic Ovary Syndrome 'PCOS' patients' stress levels.

Mindfulness-Based Stress Reduction 'MBSR' impact in PolyCystic Ovary Syndrome 'PCOS' patients stress levels: a blind randomized controlled trial in females of reproductive age.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000623796
Enrollment
40
Registered
2013-05-31
Start date
2012-09-11
Completion date
2013-03-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of this study is to measure the MBSR program efficacy in decreasing stress levels in the PCOS patients. If the MBSR program proves to be efficient in decreasing stress levels, then it should integrated in the current management, along with the treatment.

Interventions

Mindfulness-based stress reduction program, including mindfulness breathing training exercises. It is administered on enrollment day by the main investigator. The session lasts for 20 to 30 minutes, per patient. It is administered on individual basis. The investigator advises for the daily implementation of the program in daily routine, for about 15 to 20 minutes, once, daily. There is a scheduled meeting at the end of the week of 20 to 30 minutes, when the patients report on their progress and

Mindfulness-based stress reduction program, including mindfulness breathing training exercises. It is administered on enrollment day by the main investigator. The session lasts for 20 to 30 minutes, per patient. It is administered on individual basis. The investigator advises for the daily implementation of the program in daily routine, for about 15 to 20 minutes, once, daily. There is a scheduled meeting at the end of the week of 20 to 30 minutes, when the patients report on their progress and the frequency of their practice or the changes, they may observe in the past week.

Sponsors

Charikleia Stefanaki, M.D., M.Sc. Candidate
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
11 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

Patients with PCOS diagnosis, according to the Rotterdam Criteria.

Exclusion criteria

1. Pregnancy 2. Any genetic disorder or endocrine disease, which results in clinical or biochemical hyperandrogenemia. 3. Any kind of psychiatric disorder 4. Use of antipsychotic, antidepressant or anticolvusant medications 5. Current practice of any stress management technique or previous practice even in two months before the enrollment. 6. Refusal to participate or comply with the 8 weeks MBSR program 7. Participation in other studies.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026